ERYTECH Appoints Allene M. Diaz to its Board of Directors Post author:admERY Post published:September 5, 2016 Post category:Newsroom ERYTECH Pharma today announced the appointment of Allene M. Diaz to its Board of Directors as a nonvoting member (censeur). You Might Also Like ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer January 14, 2021 ERYTECH provides business update and financial results for the first half of 2015 September 28, 2015 ERYTECH announces second positive DSMB review of its Phase IIb study in Acute Myeloid Leukemia August 27, 2014
ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer January 14, 2021
ERYTECH announces second positive DSMB review of its Phase IIb study in Acute Myeloid Leukemia August 27, 2014